Differential cellular accumulation of transforming growth factor-β1, - β2, and -β3 in brains of patients who died with cerebral malaria

Journal of Infectious Diseases

Volumn 181, Issue 6, 2000, Pages 2111-2115

  Deininger, Martin H ^a   Kremsner, Peter G ^a   Meyermann, Richard ^a   Schluesener, Hermann J ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ARTICLE; BRAIN MALARIA; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; PATHOPHYSIOLOGY; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0034047282     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315493     Document Type: Article

References (15)

1. 1. Omer FM, Riley EM. Transforming growth factor beta production is inversely correlated with severity of murine malaria infection. J Exp Med 1998;188:39-48.
2. 2. Wenisch C, Parschalk B, Burgmann H, Looareesuwan S, Graninger W. Decreased serum levels of TGF-beta in patients with acute Plasmodium falciparum malaria. J Clin Immunol 1995;15:69-73.
3. 3. de-Kossodo S, Grau GE. Profiles of cytokine production in relation with susceptibility to cerebral malaria. J Immunol 1993;151:4811-20.
4. 4. Johns LD, Sriram S. Experimental allergic encephalomyelitis: neutralizing antibody to TGF beta 1 enhances the clinical severity of the disease. J Neuroimmunol 1993;47:1-7.
5. 5. Lindholm D, Castren E, Kiefer R, Zafra F, Thoenen H. Transforming growth factor-beta 1 in the rat brain: increase after injury and inhibition of astrocyte proliferation. J Cell Biol 1992;117:395-400.
6. 6. Chen TC, Hinton DR, Yong VW, Hofman FM. TGF-β2 and soluble p55 TNFR modulate VCAM-1 expression in glioma cells and brain derived endothelial cells. J Neuroimmunol 1997;73:155-61.
7. 7. Deininger MH, Meyermann R. Multiple epitope labeling by the exclusive use of alkaline phosphatase conjugates in immunohistochemistry. Histochem Cell Biol 1998;110:425-30.
8. 8. De Groot CJA, Montagne L, Barten AD, Sminia P, Van der Valk P. Expression of transforming growth factor (TGF)-β1, -β2 and -β3 isoforms and TGF-β type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures. J Neuropath Exp Neurol 1999;58:174-87.
9. 9. Peress NS, Perillo BS. Differential expression of TGF-β1, 2 and 3 isotypes in Alzheimer's disease: a comparative immunohistochemical study with cerebral infarction, aged human and mouse control brains. J Neuropath Exp Neurol 1995;54:802-11.
10. 10. Finch CE, Laping NJ, Morgan TE, Nichols NR, Pasinetti GM. TGF-beta 1 is an organizer of responses to neurodegeneration. J Cell Biochem 1993;53:314-22.
11. 11. Xiao BG, Bai XF, Zhang GX, Link H. Transforming growth factor-beta 1 induces apoptosis of rat microglia without relation to bcl-2 oncoprotein expression. Neurosci Lett 1997;226:71-4.
12. 12. Winkler MK, Beveniste EN. Transforming growth factor-beta inhibition of cytokine-induced vascular cell adhesion molecule-1 expression in human astrocytes. Glia 1998;22:171-9.
13. 13. Relf M, LeJeune S, Scott PA, et al. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res 1997;57:963-9.
14. 14. Wiseman DM, Polverini PJ, Kamp DW, Leibovich SJ. Transforming growth factor-beta (TGF beta) is chemotactic for human monocytes and induces their expression of angiogenic activity. Biochem Biophys Res Commun 1988;157:793-800.
15. 15. Demirci G, Nashan B, Pichlmayr R. Fibrosis in chronic rejection of human liver allografts: expression patterns of transforming growth factor-TGF beta 1 and TGF-beta3. Transplantation 1996;62:1776-83.